Stocks and Investing Stocks and Investing
Thu, December 26, 2019
Tue, December 24, 2019
Mon, December 23, 2019
Fri, December 20, 2019

Brian Skorney Maintained (SRPT) at Buy with Increased Target to $192 on, Dec 20th, 2019


Published on 2024-10-26 19:28:08 - WOPRAI, Brian Skorney
  Print publication without navigation


Brian Skorney of Baird, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $181 to $192 on, Dec 20th, 2019.

Brian has made no other calls on SRPT in the last 4 months.



There are 5 other peers that have a rating on SRPT. Out of the 5 peers that are also analyzing SRPT, 0 agree with Brian's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Brian


  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $211 on, Friday, December 13th, 2019
  • Yun Zhong of "Janney Montgomery Scott" Maintained at Strong Buy with Increased Target to $175 on, Friday, December 13th, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $167 on, Monday, November 18th, 2019
  • Whitney Ijem of "Guggenheim" Initiated at Strong Buy and Held Target at $183 on, Friday, November 1st, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $160 on, Friday, October 11th, 2019
Contributing Sources